Viral hepatitis in minority America.
Viral hepatitis continues as an important public health concern in the United States. Available data indicate that acute and chronic viral hepatitis remains an important cause of morbidity and mortality in this country despite the availability of immunization for hepatitis A and B and pharmacologic therapy for chronic hepatitis B and C. Minority populations within the United States are disproportionately affected by acute and chronic viral hepatitis. Many diseases, for example, Barrett's esophagus, affect ethnic groups differently. Viral hepatitis A, B, and C may demonstrate ethnic variation with regard to their epidemiology, natural history, clinicopatholgic findings, complications, and treatment outcomes. This report will review the literature regarding these areas in hepatitis A, B, and C among the African American, Hispanic American, and Native American populations of the United States.
Rawls
Renard A
RA
University of Florida Health Sciences Center at Jacksonville, Jacksonville, FL 32209, USA.
Vega
Kenneth J
KJ
D001741:Black or African American; D005006:Ethnicity; D006506:Hepatitis A / Q000208:ethnology*; D006509:Hepatitis B / Q000208:ethnology*; D006526:Hepatitis C / Q000208:ethnology*; D006630:Hispanic or Latino; D006801:Humans; D015994:Incidence; D007198:Indians, North American; D008913:Minority Groups; D016017:Odds Ratio; D011159:Population Surveillance; D015995:Prevalence; D015996:Survival Rate; D014481:United States / Q000453:epidemiology